Detalhe da pesquisa
1.
The Negative Prognostic Impact of Lymph Node Skip Metastasis in Stage III Colon Cancer With pN1 Disease: A Single-Center and Retrospective Cohort Study.
Dis Colon Rectum
; 66(10): e1032-e1042, 2023 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36538674
2.
Clinical outcome of local treatment and radical resection for pT1 rectal cancer.
Int J Colorectal Dis
; 37(8): 1845-1851, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35852585
3.
Liver-First Approach for Synchronous Colorectal Metastases: Analysis of 7360 Patients from the LiverMetSurvey Registry.
Ann Surg Oncol
; 28(13): 8198-8208, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34212254
4.
Regorafenib in Chinese patients with metastatic colorectal cancer: Subgroup analysis of the phase 3 CONCUR trial.
J Gastroenterol Hepatol
; 35(8): 1307-1316, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31900959
5.
Prognosticators of Long-Term Outcomes of TNM Stage II Colorectal Cancer: Molecular Patterns or Clinicopathological Features.
World J Surg
; 43(12): 3207-3215, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31515570
6.
Risk factors for delayed perineal wound healing and its impact on prolonged hospital stay after abdominoperineal resection.
World J Surg Oncol
; 17(1): 226, 2019 Dec 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-31864365
7.
Clinical significance of the BRAFV600E mutation in Asian patients with colorectal cancer.
Int J Colorectal Dis
; 33(9): 1173-1181, 2018 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-29869121
8.
Metastatic Malignancy to the Colon and Rectum: A Report of 14 Cases from One Single Institute.
Dig Surg
; 35(3): 261-265, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29084394
9.
Differences in gene mutations according to gender among patients with colorectal cancer.
World J Surg Oncol
; 16(1): 128, 2018 Jul 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29976257
10.
Molecular and Clinicopathological Differences by Age at the Diagnosis of Colorectal Cancer.
Int J Mol Sci
; 18(7)2017 Jul 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28678173
11.
Mutation Spectra of Common Cancer-Associated Genes in Different Phenotypes of Colorectal Carcinoma Without Distant Metastasis.
Ann Surg Oncol
; 23(3): 849-55, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26471487
12.
Improved outcomes of colorectal cancer patients with liver metastases in the era of the multidisciplinary teams.
Int J Colorectal Dis
; 31(2): 403-11, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26662193
13.
Elevated serum alpha-fetoprotein in poorly differentiated adenocarcinoma with neuroendocrine differentiation of the ascending colon: a case report.
World J Surg Oncol
; 14: 84, 2016 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26976278
14.
Regorafenib plus best supportive care versus placebo plus best supportive care in Asian patients with previously treated metastatic colorectal cancer (CONCUR): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Oncol
; 16(6): 619-29, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25981818
15.
Clinical Relevance of Plasma DNA Methylation in Colorectal Cancer Patients Identified by Using a Genome-Wide High-Resolution Array.
Ann Surg Oncol
; 22 Suppl 3: S1419-27, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25472652
16.
Concordance of Carcinoembryonic Antigen Ratio and Response Evaluation Criteria in Solid Tumors as Prognostic Surrogate Indicators of Metastatic Colorectal Cancer Patients Treated with Chemotherapy.
Ann Surg Oncol
; 22(7): 2262-8, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25586242
17.
Cancerous inhibitor of protein phosphatase 2A (CIP2A) is an independent prognostic marker in wild-type KRAS metastatic colorectal cancer after colorectal liver metastasectomy.
BMC Cancer
; 15: 301, 2015 Apr 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-25896895
18.
Genome-wide copy number changes and CD133 expression characterized distinct subset of colon polyps: differentiation between incidental polyps and cancer-associated polyps.
Int J Colorectal Dis
; 30(12): 1617-26, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26206347
19.
Comparing the effectiveness of capecitabine versus 5-fluorouracil/leucovorin therapy for elderly Taiwanese stage III colorectal cancer patients based on quality-of-life measures (QLQ-C30 and QLQ-CR38) and a new cost assessment tool.
Health Qual Life Outcomes
; 13: 61, 2015 May 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-25986478
20.
Health-related quality of life and cost comparison of adjuvant capecitabine versus 5-fluorouracil/leucovorin in stage III colorectal cancer patients.
Qual Life Res
; 24(2): 473-84, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25099199